<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 Longevity Leaders Conference



SCIENCE OF AGEING | AGE-TECH | LONGEVITY RISK

2nd Annual Conference
21-22 April 2020
133 Houndsditch Liverpool St. | London | UK

#longevityleaders
@longevityleader

Created by    LSX Logo

DOWNLOAD BROCHURE

A conference for leaders in longevity science, technology, business and finance

  

‘This is time well spent… in terms of getting yourself properly immersed into what is possibly the most important debate in policy for the next 5-10 years’
Wilf Blackburn, Chief Executive Officer, Prudential Assurance Company Singapore

Longevity Leaders World Congress

What is it and who is it for?

The Longevity Leaders World Congress is the world’s most influential and powerful global platform designed to connect longevity science leaders, health- tech and age-tech companies and investors, business and consumer innovation leaders, policy makers, health and care providers and financial service industry leaders who all share the mission of extending human health span and delivering on the promise of healthy ageing.

It is comprised of an exhibition, company showcases, three core conferences, with shared plenaries and networking.

The 3 core pillars of the congress:

  • Science Of Ageing And Age-Related Disease
  • Age-Tech
  • Longevity Risk
Longevity Leaders London Pillars

Agenda at a Glance

21-22 April

09:00


Plenary Keynotes

11:30


The Science Of Ageing Conference


The Longevity Risk Conference


The Age-Tech Conference


Biotech Showcase


Age-Tech Company Showcase

12:30


Interdisciplinary Roundtables

14:15


The Science Of Ageing Conference


The Longevity Risk Conference


The Age-Tech Conference


Biotech Showcase


Age-Tech Company Showcase

16:15


Plenary Keynotes

09:00 - 17:00

Exhibition
&
1-2-1 Partnering

Advisory Board and Key Speakers

The Science Of Ageing And Age-Related Disease

James Peyer, CEO, Apollo Ventures
James Peyer
CEO
Apollo Ventures
Aubrey de Grey, CSO, SENS Research Foundation; VP, AgeX Therapeutics
Aubrey de Grey
CSO, SENS Research Foundation;
VP, AgeX Therapeutics
Tristan Edward, CEO, Life Biosciences
Tristan Edwards
CEO
Life Biosciences
Sree Kant, Head of Business Development, Life Biosciences
Sree Kant
Head of Business Development
Life Biosciences
Joao Pedro de Magalhaes, Scientist and Futurist, University of Liverpool
Joao Pedro de Magalhaes
Scientist and Futurist
University of Liverpool
Mark Allen, CEO, Elevian
Mark Allen
CEO
Elevian
Sergey Young, Founder, Longevity Vision Fund
Sergey Young
Founder
Longevity Vision Fund
Lynne Cox, Associate Professor, University of Oxford
Lynne Cox
Associate Professor
University of Oxford

Age-Tech And Risk

John Godfrey, Head of Corporate Affairs, Legal and General
John Godfrey
Head of Corporate Affairs
Legal and General
Wilf Blackburn, CEO, Prudential Singapore
Wilf Blackburn
CEO
Prudential Singapore
Steven Baxter, Head of Longevity Research, Hymans
Steven Baxter
Head of Longevity Research
Hymans
Dominic Endicott, CEO, 4Gen Ventures
Dominic Endicott
CEO
4Gen Ventures
Tina Woods, CEO, Collider Health
Tina Woods
CEO
Collider Health
Paul Gaudin, CEO, CareRooms
Paul Gaudin
CEO
CareRooms
Andrew Fried, Life Sciences Global Industry Leader, IBM
Andrew Fried
Life Sciences Global Industry Leader
IBM
Joe Tighe, Head of Strategy, Benevolent AI
Joe Tighe
Head of Strategy
Benevolent AI

Longevity Leaders Newsletter

It's a free weekly roundup of what we’ve found interesting in the world of longevity.

Sign up today!